General experimental procedures
The FT-IR spectra were recorded on a vector 22 instrument. The 1H-NMR was recorded on a Bruker AM 300, 400 and AM X 500 NMR (Avance) instruments using the UNIX data system at 300, 400 and 500 MHz, respectively. The 13C-NMR spectrum was recorded at 75, 100 and 125 MHz, respectively using CDCL3, CD3OD and C5D5N as solvent. 1H-13C HMBC and HMQC were recorded as mentioned above. EI-MS spectra were recorded on a Finnigan MAT 312. HR-EIMS were carried out on Jeol JMS 600 mass spectrometer. Column chromatography was carried out on silica gel (M&N), 70-230 and 230-400 meshes. All solvents and chemical reagents were purchased from Merk (Darmshtot, Germany). Compounds on the TLC were detected at 254 and 366 nm and by ceric sulphate as spraying reagent.
Plant material
The aerial flowering part of Achillea tenuifolia (Asteraceae) was collected in May 2008, from populations growing in Zanjan province, Iran. The plant was identified in Department of Pharmacognosy, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran. A voucher specimen (NO.487) was deposited in the herbarium of the above mentioned college.
Extraction and isolation
The dried aerial parts of A.tenuifolia(4 Kg) were extracted by maceration with methanol (3×15 L) at room temperature, three times, each time three days. The methanolic extract was evaporated under reduced pressure to give a dark residue (300 g), which was suspended in water and defatted with petroleum ether. The defatted aqueous extract successively fractionated with dichloromethane, n-butanole (3 times each). The dichloromethane fraction (50 g) was subjected on a silica gel column chromatography using hexane with increasing gradient of EtOAC up to 100% and followed by methanol to give ten fractions.
Fraction 1 (hexane eluate) was subjected on silica gel column (Hex: CHCl3) to yield 4 sub fractions. Sub fraction B purified by preparative TLC with the system of hexane: EtOAC (8.5:1.5) to give compound 1.
Fraction 2 (hexane:EtOAC = 9.5 : 0.5 eluate )was subjected to silica gel column chromatography, using hexane: CHCl3 to give three sub fractions (M- O). Sub fraction N (hexane: CHCl3 = 6: 4 eluate) was further purified by recrystallization from MeOH to yield compound 2 .
Fraction 6 (hex: EtOAC=8:2) was rechromatographed on silica gel column (hexane: aceton=6:4) to render 8 sub fractions (a-h).Subfractions 6c, 6f was further separated on preparative TLC to yield compounds 3, 4 using hexane: Me2CO, hexane: EtOAC as mobile phase, respectively.
Fraction 9 (EtOAC: MeOH= 9.5:0.5 eluate) was loaded on silica gel column using hexane: CHCl3: MeOH (2.5:7.5:0.5) as mobile phase and afforded compound 5.
Finally fraction eluted with EtOAc: MeOH (9:1) was subjected on silica gel column using Me
2CO: MeOH as mobile phase. From fraction eluted with Me
2CO: MeOH (9.5: 0.5) obtained compound 6.The structure of all compounds have been shown in
Figure 1.
Structures of isolated compounds
Stearic acid (compound 1): White powder(10 mg); m.p. 70 °C;HR EI/MS: 284.2722 (calcd. 284.2715 For C18H36O2);EI/MS: m/z(rel.%): 284(4.7), 256(25.95), 213(11.49), 185(14.45),171(14.84), 157(17.15), 143(11.18), 129(43.89), 115(17.54), 101(11.75), 87(26.50), 73(100);1H- NMR(CDCl3,300MHZ):δ=2.17(2H, t, J=7.5HZ,H-2), 1.49(2H, m, H-3), 1.16(br s, CH2), 0.76(3H, t, J=7HZ, H-18).
Lupeol (compound 2): Colorless crystals (20 mg); m.p. 214°- 217 °C; IR (KBr)υmaxcm-1: 3400, 2950, 2890, 1510, 1360;HR EI/MS m/z: 426.6998(calcd. 426.6989 for C30H50O);EI/MS: m/z(rel.%): 426(24.77), 411(5.73), 393(2.02), 357(2.10), 302(4.30), 257(6.61), 229(6.83), 218(9.66), 207(43.76), 203(37.62), 189(57.00), 161(22.52), 121(51.33);1H-NMR(300MHZ, CDCl3): δ= 0.70(3H, s, H-24), 0.8(3H, s, H-28), 0.83(3H, s, H-25), 0.94(3H, s, H-27), 1.00(3H, s, H-23), 1.01(3H, s, H-26), 1.65(3H, s, H-30), 3.15(1H, dd, J=5.1, 11.1HZ, H-3), 4.53 (1H, br s, H-29), 4.63(1H, br s, H-29´).
3’, 5- dihydroxy- 4’, 6, 7- trimethoxyflavone (Eupatorine, compound 3): yellow solid (10 mg); m. p. 192 °C; Uv: λ
max(MeOH): 273, 340; IRυ
max (KBr)cm
-1: 3448, 1650, 1603, 1457,1270,1120,1013,840;HR EI/MS m/z: 344.0896(calcd.344.0890for C
18 H
16 O
7,);FAB MS [M+1]
+:345,[M-1]
+:343;EI-MSm/z(rel.int.): 343.8(35.13), 328(30.38), 313(100.00), 300(11.27), 196 (9.44), 180.8(12.45), 152.8(52.66), 148(14.45), 133(13.85);
1H&
13 C-NMR: see
Table 1.
| Pair proton or carbon | 5- hydroxy- 3´, 4´, 6, 7-tetramethoxy flavone, 1H- NMR,400MHZ,CDCl3 | Eupatorine, 1H-NMR,400MHZ,CDCl3 | Eupatorine, 13C-NMR, 100MHZ,CDCl3 |
|---|
| 2 | | | 163.6 |
| 3 | 6.87 | 6.55 | 104.4 |
| 4 | | | 182.6 |
| 5 | | | 156.2 |
| 6 | | | 132.5 |
| 7 | | | 158.2 |
| 8 | 6.67 | 6.52 | 94.8 |
| 9 | | | 107.0 |
| 10 | | | 152.1 |
| 1´ | | | 123.7 |
| 2´ | 7.51(d,2.0HZ) | 7.44(d,2.1) | 113.2 |
| 3´ | | | 146.4 |
| 4´ | | | 151.2 |
| 5´ | 7.12(d,8.4HZ) | 6.91(d,8.8HZ) | 111.7 |
| 6´ | 7.57(dd,8.4,2.0HZ) | 7.38(dd,8.8,2.1HZ) | 118.8 |
| 6-OMe | 3.79 | 3.89 | 55.9 |
| 7-OMe | 3.98 | 3.94 | 60.9 |
| 4´-OMe | 3.86 | 3.97 | 56.2 |
| 3´- OMe | 3.95 | | |
5- hydroxy- 3’, 4’, 6, 7- tetramethoxyflavone (compound 4):pale yellow crystals (10.5 mg); m. p. 195 °C; Uv:λ
max(MeOH):270,340;IRυ
max (KBr)cm
-1:3530,1660,1605,1460,1273,1130,840,800; HR EI/MS m/z: 358.1047 (calcd.358.1053 for C
19H
18 O
7,);FAB MS [M+1]
+:359,[M-1]
+:357; EIMSm/z(rel.int.): 358(57.04), 343(50.2), 328(100.00), 313(98.6), 299(19.75), 285(32.8), 196(20), 181(30.5), 162(25.25), 153(80);
1H- NMR: see
Table 1.
Daucosterol(β- sitosterol 3-O- β- D- glucopyranoside, compound 5): White powder (25 mg); m. p. 278°- 282 °C;[α]: -14.5°; IR(KBr)υmax: 3460, 3050, 1650 cm-1;HR EI/MS m/z : 576.4386 (calcd.576.4389for C35H60O6); FAB MS[M-1]+: 575; EI/MS m/z(rel.%): 414(8.4), 399(8.1), 396(100.0), 381 (14.6), 329(4.5), 303(6.5), 275(9.9), 273(4.9), 255(20.2);1H-NMR(C5D5N, 500MHZ): δ= 0.64(3H, s, H-18), 0.83(3H, d, J=7.0HZ, H-27), 0.86(3H, d, J=7.0HZ, H-26), 0.92(3H, s, H-19), 0.96(3H, d, J=6.5HZ, H-21), 3.97(1H, m, H-3), 4.27-4.58(m, Glc-H), 5.04 (1H, d, J=8.0HZ,H-1´).
2,4-dihydroxy-methyl benzoate (compound 6):Brown solid (12 mg); m. p. 88°- 95 °C; HR EI/MS m/z 168.0417 (calcd.168.0423 for C8H8O4); EI/MS m/z(rel.%): 168.0 (100.00), 152.9 (73.29), 136.0 (25.90), 125.0(4.76), 107.9 (16.28), 97.0 (48.67), 84.9 (48.37);1H-NMR (CD3OD, 500MHZ): δ= 3.87(3H, s, OMe), 6.77 (1H,d,J=7.5HZ,H-5), 7.50 (1H, d, J=7.5HZ, H-6), 7.57(1H, s, H-3).